Clinical trials
Not yet recruiting Phase 3 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daiichi Sankyo | 1 |
| Genmab | 1 |
| GlaxoSmithKline | 1 |
| Incyte Corporation | 1 |
| Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 1 |
| NHS Grampian | 1 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| Tongji Hospital | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 10 |
| Fallopian Tube Neoplasms | 3 |
| Carcinoma, Ovarian Epithelial | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.